Cargando…
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.
Inactivation of the tumour-suppressor gene p53 has been described as one of the most common molecular changes found in lung tumours. Our purpose was to study the prognostic value of p53 alterations and to determine whether some specific mutation type in the p53 gene could be associated with poor cli...
Autores principales: | Vega, F. J., Iniesta, P., Caldés, T., Sanchez, A., López, J. A., de Juan, C., Diaz-Rubio, E., Torres, A., Balibrea, J. L., Benito, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223785/ https://www.ncbi.nlm.nih.gov/pubmed/9218731 |
Ejemplares similares
-
Prognostic value of genomic damage in non-small-cell lung cancer.
por: de Juan, C., et al.
Publicado: (1998) -
Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications
por: Iniesta, P, et al.
Publicado: (2004) -
Expression of high p53 levels in colorectal cancer: a favourable prognostic factor
por: Adrover, E, et al.
Publicado: (1999) -
Widespread Shortening of 3’ Untranslated Regions and Increased Exon Inclusion Are Evolutionarily Conserved Features of Innate Immune Responses to Infection
por: Pai, Athma A., et al.
Publicado: (2016) -
Mutations in p53 Gene Exons in a Sample from the South of Spain in Oral Cancer
por: Martín-Lozano, Guiomar, et al.
Publicado: (2021)